Raf Mols

4.1k total citations
53 papers, 2.8k citations indexed

About

Raf Mols is a scholar working on Oncology, Pharmaceutical Science and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Raf Mols has authored 53 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Pharmaceutical Science and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Raf Mols's work include Drug Solubulity and Delivery Systems (15 papers), Drug Transport and Resistance Mechanisms (15 papers) and Advanced Drug Delivery Systems (9 papers). Raf Mols is often cited by papers focused on Drug Solubulity and Delivery Systems (15 papers), Drug Transport and Resistance Mechanisms (15 papers) and Advanced Drug Delivery Systems (9 papers). Raf Mols collaborates with scholars based in Belgium, United States and Germany. Raf Mols's co-authors include Patrick Augustijns, Pieter Annaert, Eric Schoenmakers, Jörn Bullerdiek, Jan Tack, Sylke Wanschura, Wim J.M. Van de Ven, Herman Van den Berghe, Joachim Brouwers and Johan A. Martens and has published in prestigious journals such as Nature Communications, Nature Genetics and Gastroenterology.

In The Last Decade

Raf Mols

53 papers receiving 2.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Raf Mols 851 712 559 507 333 53 2.8k
Diego A. Chiappetta 1.1k 1.3× 979 1.4× 358 0.6× 368 0.7× 272 0.8× 87 3.7k
Shinji Sakuma 1.1k 1.2× 713 1.0× 404 0.7× 271 0.5× 79 0.2× 103 2.4k
Wenlei Jiang 545 0.6× 608 0.9× 204 0.4× 236 0.5× 228 0.7× 119 2.9k
Johan Karlsson 817 1.0× 1.6k 2.2× 1.6k 2.9× 300 0.6× 132 0.4× 50 4.6k
Bastiaan Nuijen 524 0.6× 1.0k 1.4× 829 1.5× 184 0.4× 269 0.8× 122 2.7k
Gregory T. Knipp 524 0.6× 763 1.1× 722 1.3× 203 0.4× 81 0.2× 62 2.6k
Jochem Alsenz 623 0.7× 731 1.0× 458 0.8× 399 0.8× 52 0.2× 52 2.7k
Toshikiro Kimura 1.7k 2.0× 951 1.3× 780 1.4× 474 0.9× 153 0.5× 111 3.6k
Chang‐Koo Shim 1.9k 2.2× 1.4k 2.0× 898 1.6× 190 0.4× 386 1.2× 181 4.8k
Ken‐ichi Ogawara 885 1.0× 1.0k 1.4× 483 0.9× 300 0.6× 229 0.7× 123 3.0k

Countries citing papers authored by Raf Mols

Since Specialization
Citations

This map shows the geographic impact of Raf Mols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raf Mols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raf Mols more than expected).

Fields of papers citing papers by Raf Mols

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raf Mols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raf Mols. The network helps show where Raf Mols may publish in the future.

Co-authorship network of co-authors of Raf Mols

This figure shows the co-authorship network connecting the top 25 collaborators of Raf Mols. A scholar is included among the top collaborators of Raf Mols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raf Mols. Raf Mols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mitrová, Katarína, Mette Julsgaard, Patrick Augustijns, et al.. (2024). Tofacitinib in Pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood, and Breast Milk Concentrations. Clinical Gastroenterology and Hepatology. 23(1). 163–165.e3. 13 indexed citations
3.
Steenackers, Nele, Tim Vanuytsel, Patrick Augustijns, et al.. (2023). Effect of sleeve gastrectomy and Roux-en-Y gastric bypass on gastrointestinal physiology. European Journal of Pharmaceutics and Biopharmaceutics. 183. 92–101. 9 indexed citations
4.
Brouwers, Joachim, et al.. (2023). Characterization of neonatal and infant enterostomy fluids. International Journal of Pharmaceutics. 639. 122943–122943. 6 indexed citations
5.
Augustijns, Patrick, et al.. (2022). Investigating the Mechanisms behind the Positive Food Effect of Abiraterone Acetate: In Vitro and Rat In Situ Studies. Pharmaceutics. 14(5). 952–952. 8 indexed citations
6.
Wauters, Lucas, Raúl Y. Tito, Matthias Ceulemans, et al.. (2021). Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia. International Journal of Molecular Sciences. 22(24). 13609–13609. 32 indexed citations
7.
Vergote, Valentijn, Lies Laenen, Raf Mols, et al.. (2021). Chloroquine, an Anti-Malaria Drug as Effective Prevention for Hantavirus Infections. Frontiers in Cellular and Infection Microbiology. 11. 580532–580532. 6 indexed citations
8.
López‐Yerena, Anallely, Anna Vallverdú‐Queralt, Raf Mols, et al.. (2020). Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134”. Pharmaceutics. 12(12). 1221–1221. 6 indexed citations
9.
Hoon, Jan de, John Morales, Carolina Varon, et al.. (2019). Codeine delays gastric emptying through inhibition of gastric motility as assessed with a novel diagnostic intragastric balloon catheter. Neurogastroenterology & Motility. 32(1). e13733–e13733. 16 indexed citations
10.
Rubbens, Jari, Raf Mols, Joachim Brouwers, & Patrick Augustijns. (2018). Exploring gastric drug absorption in fasted and fed state rats. International Journal of Pharmaceutics. 548(1). 636–641. 20 indexed citations
11.
Αbeele, Jens Van Den, Ronald Schilderink, Felix Schneider, et al.. (2017). Gastrointestinal and Systemic Disposition of Diclofenac under Fasted and Fed State Conditions Supporting the Evaluation of in Vitro Predictive Tools. Molecular Pharmaceutics. 14(12). 4220–4232. 29 indexed citations
12.
Berben, Philippe, Raf Mols, Joachim Brouwers, Jan Tack, & Patrick Augustijns. (2017). Gastrointestinal behavior of itraconazole in humans – Part 2: The effect of intraluminal dilution on the performance of a cyclodextrin-based solution. International Journal of Pharmaceutics. 526(1-2). 235–243. 30 indexed citations
13.
Vanstraelen, Kim, Johan Maertens, Patrick Augustijns, et al.. (2015). Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole. Clinical Pharmacokinetics. 54(11). 1151–1160. 17 indexed citations
14.
Riethorst, Danny, Raf Mols, Guus Duchateau, et al.. (2015). Characterization of Human Duodenal Fluids in Fasted and Fed State Conditions. Journal of Pharmaceutical Sciences. 105(2). 673–681. 203 indexed citations
15.
Eerdenbrugh, Bernard Van, Michiel Van Speybroeck, Raf Mols, et al.. (2009). Itraconazole/TPGS/Aerosil®200 solid dispersions. European Journal of Pharmaceutical Sciences. 38(3). 270–278. 52 indexed citations
16.
Mols, Raf, Joachim Brouwers, Alfred H. Schinkel, Pieter Annaert, & Patrick Augustijns. (2009). INTESTINAL PERFUSION WITH MESENTERIC BLOOD SAMPLING IN WILD-TYPE AND KNOCKOUT MICE. Drug Metabolism and Disposition. 37(6). 1334–1337. 33 indexed citations
17.
Mols, Raf, S. Deferme, & Patrick Augustijns. (2005). Sulfasalazine transport in in-vitro, ex-vivo and in-vivo absorption models: contribution of efflux carriers and their modulation by co-administration of synthetic nature-identical fruit extracts. Journal of Pharmacy and Pharmacology. 57(12). 1565–1573. 26 indexed citations
18.
Augustijns, Patrick & Raf Mols. (2004). HPLC with programmed wavelength fluorescence detection for the simultaneous determination of marker compounds of integrity and P-gp functionality in the Caco-2 intestinal absorption model. Journal of Pharmaceutical and Biomedical Analysis. 34(5). 971–978. 40 indexed citations
19.
Mols, Raf, et al.. (2002). Involvement of a palindromic chromosome 22‐specific low‐copy repeat in a constitutional t(X; 22)(q27;q11). Clinical Genetics. 62(5). 410–414. 16 indexed citations
20.
Petit, Marleen M.R., et al.. (1996). LPP,the Preferred Fusion Partner Gene ofHMGICin Lipomas, Is a Novel Member of the LIM Protein Gene Family. Genomics. 36(1). 118–129. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026